MFDS
- Marketing authorisation holder: FEINSTEIN
- Status: likely_approved
🇰🇷 Fluorodopa F18 in South Korea
Fluorodopa F18 (FLUORODOPA) regulatory status in South Korea.
Marketing authorisation
Fluorodopa F18 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Fluorodopa F18 approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Fluorodopa F18 in South Korea?
FEINSTEIN holds the South Korean marketing authorisation.